Abstract
AbstractPatients with schizophrenia have a high prevalence of cigarette smoking and respond poorly to conventional treatments, highlighting the need for new therapies. We conducted a mechanistic, proof-of-concept study using bilateral deep repetitive transcranial magnetic stimulation (dTMS) of insular and prefrontal cortices at high frequency, using the specialized H4 coil. Feasibility of dTMS was tested for disruption of tobacco self-administration, insula target engagement, and insula circuit modulation, all of which were a priori outcomes of interest. Twenty patients completed the study, consisting of weekday dTMS sessions (randomization to active dTMS or sham; double-blind; 10 patients per group), a laboratory tobacco self-administration paradigm (pre/post assessments), and multimodal imaging (three MRI total sessions). Results showed that participants assigned to active dTMS were slower to initiate smoking their first cigarette compared with sham, consistent with smoking disruption. The imaging analyses did not reveal significant Time × Group interactions, but effects were in the anticipated directions. In arterial spin labeling analyses testing for target engagement, an overall decrease in insula blood flow, measured during a post-treatment MRI versus baseline, was numerically more pronounced in the active dTMS group than sham. In fMRI analyses, resting-state connectivity between the insula and default mode network showed a numerically greater change from baseline in the active dTMS group than sham, consistent with a functional change to insula circuits. Exploratory analyses further suggested a therapeutic effect of dTMS on symptoms of psychosis. These initial observations pave the way for future confirmatory studies of dTMS in smoking patients with schizophrenia.
Funder
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
Publisher
Springer Science and Business Media LLC
Reference66 articles.
1. George, T. P. & Ziedonis, D. M. Addressing tobacco dependence in psychiatric practice: Promises and pitfalls. Can. J. Psychiatry 54, 353–355 (2009).
2. Ziedonis, D. et al. Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine Tobacco Res.: Off. J. Soc. Res. Nicotine Tobacco 10, 1691–1715 (2008).
3. de Leon, J. & Diaz, F. J. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizopr. Res. 76, 135–157 (2005).
4. Lucatch, A. M., Lowe, D. J. E., Clark, R. C., Kozak, K. & George, T. P. Neurobiological determinants of tobacco smoking in schizophrenia. Front. Psychiatry/Front. Res. Found. 9, 672 (2018).
5. Cather, C., Pachas, G. N., Cieslak, K. M. & Evins, A. E. Achieving smoking cessation in individuals with schizophrenia: Special considerations. CNS Drugs 31, 471–481 (2017).
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献